FDA Inspection 808638 — Elanco Clinton Laboratories

Elanco Clinton Laboratories — FEI 1820381

The FDA completed an inspection of Elanco Clinton Laboratories on Nov 28, 2012 in Clinton, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 28, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clinton, IN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.